Several studies have shown that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of coronavirus disease 2019 (COVID-19) pandemic, affects children with mild symptoms, unlike older age groups. There is a scarcity of research related to the assessment of durability and strength of antibodies generated in children post-COVID-19. Background Assessing the strength and durability